Chalfont St. Giles, UK – September 22, 2016 – The Automated Breast Ultrasound (ABUS) system is found to have significantly improved cancer detection in women with dense breast tissue when used together with mammography. The European Asymptomatic Screening Study aimed to evaluate the impact of ABUS in conjunction with full field digital screening mammography (FFDSM)... Read more
CHALFONT ST. GILES, UK – 30 September 2016 –At the International Society for Cellular Therapy’s Regional Meeting in Memphis, TN, GE Healthcare’s recently acquired Biosafe Group introduces Sefia, a state-of-the-art, multi-function platform which uses a combination of continuous-flow centrifugation, temperature control and fluidic management to enable purification, concentration, washing and final formulation during cell processing. Combined with GE... Read more
Chalfont St. Giles, UK and Songdo, Korea – 29 September 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries, announced today the opening of a GE Fast Trak Center in Songdo, Incheon Metropolitan City, South Korea. The new USD 7.4 million Center will... Read more
Rome – 22 September 2016 – GE Healthcare and Trice Imaging, Inc., a cloud-based medical imaging solutions provider, today announced a commercial partnership to provide a new way for clinicians to connect with their colleagues and patients. This solution – called Tricefy™ – adds cloud-based image sharing, diagnostic collaboration, remote reviewing, archiving and Electronic Health Record... Read more
CHALFONT ST. GILES, UK and YAROSLAVL, RUSSIA – 22 September 2016 – R-Pharm Group has opened an innovative biopharmaceutical production plant equipped with GE Healthcare’s FlexFactory™ manufacturing platform in Yaroslavl, Russia. R-Pharm’s FlexFactory will support the mass production of biologics and biosimilars focused on treating autoimmune diseases and cancer, and allowing for increased access to these... Read more
CORK – 19 September, 2016 – Ireland’s Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor TD, today announced that GE (NYSE:GE) is to invest €150 million in a new biopharmaceutical manufacturing campus on Industrial Development Agency (IDA) Ireland’s strategic site at Loughbeg, Ringaskiddy, Co. Cork. GE BioPark Cork, subject to contract and planning approvals,... Read more
Metrohm is pleased to present «Pharmaceutical analysis», a dedicated online resource providing an overview of the most important methods and applications for the determination of active ingredients, excipients, and impurities in pharmaceuticals. «Pharmaceutical analysis» draws on Metrohm’s comprehensive expertise in chemical analysis for the quality control of pharmaceuticals. Using the U.S. Pharmacopeia as a reference,... Read more
CHALFONT ST. GILES, UK and CHARLOTTE, NC – 17 August 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries and Sealed Air Corporation, a global manufacturer of primary films for pharmaceutical solutions, today announced the expansion of a strategic alliance designed to further... Read more
We are making the chemical engineer’s life a bit more comfortable: A new section on the Metrohm website takes a comprehensive look at the methods and applications used in the quality control of the industrial manufacturing of basic chemicals, solvents, colorants, and their intermediates. Whether you are looking for a specific parameter and suitable methods... Read more
VENLO, The Netherlands, July 23 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced that its offer to exchange cash and stock for all outstanding shares of Digene Corporation (Nasdaq: DIGE) expired as scheduled at 11:59 p.m., New York City time, on Friday, July 20, 2007. All conditions of the exchange offer... Read more